Hyaluronic Acidobservational2000

Interaction of hyaluronic acid with mucin, evaluated by gel permeation chromatography.

Research communications in molecular pathology and pharmacology

confidence

Key findings

Methods paper: developed gel permeation chromatography method to evaluate HA-mucin interaction using microgram quantities of mucin.

View source on PubMed (PMID 10741378) ↗

Sample size
N/A
Population
In vitro study (no human or animal subjects); HA from human umbilical cord or rooster comb, porcine gastric mucin
Dosing
N/A
Duration
N/A
Route
N/A
Blinding
not_reported
Controls
none
Drug class
glycosaminoglycan
Full abstract

Hyaluronic acid (HA) is known to increase the ocular bioavailability of ophthalmic drugs not only for its viscous properties but also for its specific affinity for ocular mucins. This phenomenon, called bio- or mucoadhesion, can be evaluated in vitro by mechanical tests which, however, require considerable amounts of mucin (M) that are difficult to obtain from ocular surfaces. Thus, we developed an alternative method, based on gel permeation liquid chromatography, to examine the interaction of HA with microgram quantities of mucin. HA (from human umbilical cord or rooster comb) were fractionated using a Sepharose CL-4B column, before and after incubation with porcine gastric mucin (PGM), and the fractions were analyzed by a specific assay based on the histological dye Stains-all. PGM interacted with high molecular weight (M.W). HA, causing the displacement of low M.W., non-covalently bound, HA fragments, which were eluted under a distinct chromatographic peak. By quantitating the relative area of this peak, an evaluation of the mucoadhesion of HA could be obtained. This method could be useful to study the interaction between HA and microgram quantities of ocular M (mucin), obtained from individual patients or normal subjects.

Research information, not medical advice. StudyKit summarizes published studies to help you understand your protocol. It does not diagnose, treat, or replace a clinician. Talk to a qualified provider before changing anything you take.